by Jim Robick | May 20, 2020 | Blog
If your company’s pharmaceutical spending isn’t a problem yet, look out. Studies show that pharmaceutical costs are rising at three times the rate of medical inflation, and these expenses often account for 30% of an employer’s total health benefits spending. A major... 
by Jim Robick | May 7, 2020 | Blog
For many CEOs and CFOs, health benefits packages are their second or third biggest annual expense, and the prices increase every year. This does not have to happen. While most companies with fully-funded plans endure price hikes of approximately 10% each year,...
Recent Comments